cupabimod (AMG0103) / AnGes MG, Shionogi  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cupabimod (AMG0103) / AnGes MG, Shionogi
NCT03263611: AMG0103 in Subjects With Chronic Discogenic Lumbar Back Pain

Completed
1b
25
US
Placebo, AMG0103
AnGes, Inc.
Degenerative Disc Disease
02/21
02/21

Download Options